We use cookies to provide you with the best of services and customized features. By continuing to browse this website, you give your informed consent to our Cookie Policy.
SII is seeking regulatory nod from the Indian government to start the trials for this vaccine. Company sources said it can start the trials by January 2021 once the regulatory approval is received.
